Sponsors
The bill increases transparency and congressional oversight about COVID‑19 origins, but that transparency risks exposing sensitive intelligence methods and sources, straining review processes, and complicating diplomacy.
All Americans (taxpayers and the public) gain access to more intelligence about COVID‑19 origins when declassified reports are publicly released, increasing transparency about the pandemic's origins.
Congressional intelligence committees (and by extension American voters) receive fuller, less‑redacted materials, improving legislative oversight of the intelligence community’s handling of pandemic‑origin information.
State and local governments and public‑health agencies can use released findings—such as evidence about PRC efforts to impede information sharing—to inform public‑health policy and future pandemic preparedness.
The public (taxpayers) may still receive incomplete answers because required redactions — and the 180‑day rush to declassify — could lead to over‑redaction or hurried reviews that omit key details.
Intelligence personnel, sources, and foreign partners could be put at risk if declassification inadvertently exposes operational details, collection methods, or sensitive sources.
Naming specific foreign‑government misconduct publicly could complicate U.S. diplomatic relations and provoke reprisals or retaliation that harm U.S. foreign policy interests and possibly American citizens abroad.
Based on analysis of 2 sections of legislative text.
Requires DNI and intelligence agency heads to declassify and publicly release intelligence on COVID‑19 origins and PRC efforts to impede investigations, and provide unredacted versions to congressional intelligence committees within 180 days.
Introduced December 1, 2025 by Todd Young · Last progress December 1, 2025
Requires the Director of National Intelligence and the heads of intelligence community elements to complete declassification reviews and publicly release intelligence products about the origins of COVID-19 and specified efforts by PRC actors to impede information-sharing or investigations. The agencies must provide redacted public releases as appropriate and deliver unredacted versions to the congressional intelligence committees, with all work completed within 180 days of enactment. The review must cover research at PRC research centers (including the Wuhan Institute of Virology), Gain‑of‑Function research intent, foreign and PRC funding/direction of coronavirus research, and PRC actions to obstruct investigations, pressure third parties, impede R&D, or promote alternative narratives; public releases may redact sources, methods, and US persons’ identities to protect classified information and privacy.